|
시장보고서
상품코드
1134154
세계의 미결정 셀룰로오스 시장 예측(-2027년)Global Microcrystalline Cellulose Market Forecast to 2027 |
||||||
세계의 미결정 셀룰로오스 시장 규모는 2027년까지의 조사 기간 중 6.78%의 CAGR로 성장하며, 2027년에는 12억 470만 달러를 돌파할 것으로 예측됩니다. 식품 및 음료 산업의 성장, 구매자 생활 양식의 변화, 1인당 현금흐름의 증가, 개인 구매력의 상승은 미결정 셀룰로오스 시장의 성장을 촉진하고 있습니다. 그러나 미결정 셀룰로오스 대체품의 출현은 시장의 성장을 억제할 것으로 생각되고 있습니다.
세계의 미결정 셀룰로오스 시장에 대해 조사분석했으며, 시장 역학, 시장 분석, 경쟁 구도, 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 주요 요약
- 시장의 매력 분석
- 세계의 미결정 셀룰로오스 시장 : 공급원 별
- 세계의 미결정 셀룰로오스 시장 : 최종 용도 산업별
- 세계의 미결정 셀룰로오스 시장 : 지역별
제2장 시장 서론
- 정의
- 조사 범위
- 시장 구조
제3장 조사 방법
- 조사 프로세스
- 1차 조사
- 2차 조사
- 시장 규모 추정
- 톱다운과 보텀업 어프로치
- 예측 모델
- 가정 리스트
제4장 시장 역학
- 서론
- 촉진요인
- 제약 업계에서 미결정 셀룰로오스의 수요 증가
- 가공식품 산업에서 수요의 지속적인 성장
- 억제요인
- 대체품 가용성
- 기회
- 세계 시장에서 비목재 기반 미결정 셀룰로오스의 개발과 사용
- 화장품 및 퍼스널케어 제품에 대한 미결정 셀룰로오스의 사용 증가
제5장 시장 요인 분석
- 공급망 분석
- 원료 공급업체
- 미결정 셀룰로오스 제조업체
- 유통 및 판매채널
- 최종 용도
- Porter's Five Forces 분석
- 신규 진출업체의 위협
- 경쟁 기업간 경쟁 관계
- 대체품의 위협
- 공급 기업의 교섭력
- 구매자의 교섭력
- 가격의 개요, 달러/톤(2018-2020년)
- COVID-19의 미결정 셀룰로오스 산업에 대한 영향
- 공급 시나리오의 개요
- 미결정 셀룰로오스 공급망 COVID-19의 영향
- COVID-19에 의한 수요 변화에 관한 정성 분석
- COVID-19의 세계 경제에 대한 영향
- COVID-19의 건수
- COVID-19의 영향에 대항하기 위한 정부의 주요 정책
제6장 세계의 미결정 셀룰로오스 시장 : 공급원별
- 개요
- 미결정 셀룰로오스 : 시장 추정과 예측 : 공급원별(2018-2027년)
- 목재 기반
- 목재 기반 : 추정·예측(2018-2027년) : 지역별
- 비목재 기반
- 비목재 기반 : 추정·예측(2018-2027년) : 지역별
제7장 세계의 미결정 셀룰로오스 시장 : 최종 용도 산업별
- 개요
- 미결정 셀룰로오스 : 시장 추정과 예측(2018-2027년) : 최종 용도 산업별
- 의약품
- 의약품 : 추정·예측(2018-2027년) : 지역별
- 식품 및 음료
- 식품 및 음료 : 추정·예측(2018-2027년) : 지역별
- 화장품·퍼스널케어
- 화장품·퍼스널케어 : 추정·예측(2018-2027년) : 지역별
- 기타
- 기타 : 추정·예측(2018-2027년) : 지역별
제8장 세계의 미결정 셀룰로오스 시장 : 지역별
- 개요
- 북미
- 미국
- 캐나다
- 유럽
- 독일
- 영국
- 러시아
- 프랑스
- 스페인
- 이탈리아
- 기타 유럽
- 아시아태평양
- 중국
- 일본
- 인도
- 한국
- 호주와 뉴질랜드
- 인도네시아
- 태국
- 기타 아시아태평양
- 중동 및 아프리카
- GCC 국가
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 브라질
- 멕시코
- 아르헨티나
- 기타 라틴아메리카
제9장 경쟁 구도
- 경쟁 개요
- 세계 시장 전략 분석
- 경쟁 벤치마킹
제10장 기업 개요
- DUPONT
- ASAHI KASEI CORPORATION
- ROQUETTE FRERES
- MINGTAI CHEMICAL CO., LTD
- ACCENT MICROCELL PVT. LTD
- JRS PHARMA
- PHARMATRANS-SANAQ AG
- DFE PHARMA
- WEI MING PHARMACEUTICAL MFG. CO., LTD
- SIGACHI INDUSTRIES PVT.LTD.
제11장 부록
- 참고 문헌
- 관련 리포트
Global Microcrystalline Cellulose Market: Forecast till 2027
Market Overview
As per Market Research Future (MRFR) Analysis, the worldwide Microcrystalline Cellulose Market is supposed to show a solid CAGR of 6.78% to outperform USD 1,204.7 Million by the conjecture period 2027. Microcrystalline cellulose (MCC) is a refined wood pound used as a foe of a structure up subject matter expert, an emulsifier, a fat substitute, a texturizer, an extender, and a structure trained professional. It is customarily used as tablets or upgrades. It is made by controlled hydrolysis of significantly separated alpha-cellulose, obtained from regularly happening wood cellulose with mineral acids. Microcrystalline cellulose is additionally applicable in private consideration and corrective items, setting out beneficial open doors for market players.
Microcrystalline Cellulose Market is supposed to observe a significant market development rate during the conjecture time frame. The provincial market development is driven by the rising interest for MCC as drug excipients. Additionally, the rising food and drink industry, changing buyer ways of life, developing per capita discretionary cashflow, and rising buying power of individuals are supposed to observe the biggest market development of the microcrystalline cellulose market during the conjecture time frame. Be that as it may, the accessibility of microcrystalline cellulose substitutes is supposed to control the development of this market.
Market Segmentation
Worldwide Microcrystalline Cellulose Market has been ordered into Source, End-Use Industry, and Region.
In light of source type, the Global Microcrystalline Cellulose Market has been partitioned into wood-based and non-wood-based. The wood-based source portion is supposed to enlist the most noteworthy market development attributable to over half of the worldwide market share in 2019. This polymer is broadly utilized as a non-stick covering for dish and cookware, protection of wiring in aviation and electrical businesses, clinical machines, and auto and modern items.
As far as the end-use industry, the microcrystalline cellulose market has been ordered into drug, food and drinks, beauty care products and individual consideration, and others. The drug section drove the worldwide market with over 40% market share in 2019. among individuals. The food and drink section is assessed to hold a critical market share in the worldwide microcrystalline cellulose market.
Local Analysis
Topographically, the Microcrystalline Cellulose Market has been spread across five areas, specifically, Asia-Pacific, North America, Europe, Latin America, and the Middle East and Africa.
The market in Asia-Pacific represented the biggest market portion of over 40% market in 2019, with a market worth of roughly USD 587.3 million. The local market development is driven by the rising urbanization and developing industrialization in the creating economies of Asia-Pacific, particularly in China, Japan, and southeast Asian countries.
North America held the second-biggest market share attributable to the presence of laid out players in the district, with the US being the biggest market.
Central parts
The Major players working in the worldwide microcrystalline cellulose market are DuPont, Asahi Kasei Corporation, JRS Pharma, Roquette Freres, Mingtai Chemical Co., Ltd., Accent Microcell Pvt. Ltd., JRS Pharma, Pharmatrans-Sanaq AG, DFE Pharma, Weiming Pharmaceutical MFG. Co., Ltd, and Sigachi Industries Pvt. Ltd..
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
- 1.1 MARKET ATTRACTIVENESS ANALYSIS 18
- 1.1.1 GLOBAL MICROCRYSTALLINE CELLULOSE MARKET, BY SOURCE 18
- 1.1.2 GLOBAL MICROCRYSTALLINE CELLULOSE MARKET, BY END-USE INDUSTRY 19
- 1.1.3 GLOBAL MICROCRYSTALLINE CELLULOSE MARKET, BY REGION 20
2 MARKET INTRODUCTION
- 2.1 DEFINITION 21
- 2.2 SCOPE OF THE STUDY 21
- 2.3 MARKET STRUCTURE 22
3 RESEARCH METHODOLOGY
- 3.1 RESEARCH PROCESS 23
- 3.2 PRIMARY RESEARCH 24
- 3.3 SECONDARY RESEARCH 25
- 3.4 MARKET SIZE ESTIMATION 25
- 3.5 TOP-DOWN AND BOTTOM-UP APPROACH 26
- 3.6 FORECAST MODEL 27
- 3.7 LIST OF ASSUMPTIONS 28
4 MARKET DYNAMICS
- 4.1 INTRODUCTION 29
- 4.2 DRIVERS 30
- 4.2.1 INCREASING DEMAND OF MICROCRYSTALLINE CELLULOSE IN PHARMACEUTICAL INDUSTRY 30
- 4.2.2 SUSTAINABLE GROWTH OF DEMAND IN PROCESSED FOOD INDUSTRY 30
- 4.3 RESTRAINT 31
- 4.3.1 AVAILABILITY OF SUBSTITUTES 31
- 4.4 OPPORTUNITIES 32
- 4.4.1 DEVELOPMENT AND USE OF NON-WOOD BASED MICROCRYSTALLINE CELLULOSE IN THE GLOBAL MARKET 32
- 4.4.2 INCREASING USE OF MICROCRYSTALLINE CELLULOSE FOR COSMETICS AND PERSONAL CARE PRODUCTS 32
5 MARKET FACTOR ANALYSIS
- 5.1 SUPPLY CHAIN ANALYSIS 34
- 5.1.1 RAW MATERIAL SUPPLIERS 34
- 5.1.2 MICROCRYSTALLINE CELLULOSE MANUFACTURERS 35
- 5.1.3 DISTRIBUTION & SALES CHANNEL 35
- 5.1.4 END USE 35
- 5.2 PORTER'S FIVE FORCES ANALYSIS 36
- 5.2.1 THREAT OF NEW ENTRANTS 36
- 5.2.2 INTENSITY OF COMPETITIVE RIVALRY 37
- 5.2.3 THREAT OF SUBSTITUTES 37
- 5.2.4 BARGAINING POWER OF SUPPLIERS 37
- 5.2.5 BARGAINING POWER OF BUYERS 37
- 5.3 PRICING OVERVIEW, USD/TON (2018-2020) 37
- 5.4 IMPACT OF COVID-19 ON THE MICROCRYSTALLINE CELLULOSE INDUSTRY 38
- 5.4.1 OVERVIEW OF SUPPLY SCENARIO 38
- 5.4.2 IMPACT OF COVID-19 ON THE SUPPLY CHAIN OF MICROCRYSTALLINE CELLULOSE 38
- 5.4.2.1 RAW MATERIALS 38
- 5.4.2.1 MICROCRYSTALLINE CELLULOSE MANUFACTURERS 38
- 5.4.2.2 SALES & DISTRIBUTION CHANNELS 38
- 5.4.2.3 END USERS 39
- 5.4.3 QUALITATIVE ANALYSIS ON CHANGE IN DEMAND DUE TO COVID-19 39
- 5.4.4 IMPACT OF COVID ON GLOBAL ECONOMY 40
- 5.4.5 NUMBER OF COVID-19 CASES 41
- 5.4.6 MAJOR GOVERNMENT POLICIES TO COUNTER THE IMPACT OF COVID-19 42
- 5.4.6.1 US 42
- 5.4.6.1.1 FISCAL POLICIES 42
- 5.4.6.1.2 MONETARY AND MACRO-FINANCIAL 42
- 5.4.6.2 EUROPEAN UNION 42
- 5.4.6.2.1 FISCAL POLICIES 42
- 5.4.6.2.2 MONETARY AND MACRO-FINANCIAL 43
- 5.4.6.3 CHINA 43
- 5.4.6.3.1 FISCAL POLICIES 43
- 5.4.6.3.2 MONETARY AND MACRO-FINANCIAL 43
- 5.4.6.4 INDIA 44
- 5.4.6.4.1 FISCAL POLICIES 44
- 5.4.6.4.2 MONETARY AND MACRO-FINANCIAL 44
6 GLOBAL MICROCRYSTALLINE CELLULOSE MARKET, BY SOURCE
- 6.1 OVERVIEW 45
- 6.1.1 MICROCRYSTALLINE CELLULOSE: MARKET ESTIMATES & FORECAST BY SOURCE, 2018-2027 46
- 6.1.2 MICROCRYSTALLINE CELLULOSE: MARKET ESTIMATES & FORECAST BY SOURCE, 2018-2027 47
- 6.2 WOOD BASED 48
- 6.2.1 WOOD BASED: MARKET ESTIMATES & FORECAST BY REGION, 2018-2027 48
- 6.3 NON-WOOD BASED 49
- 6.3.1 NON-WOOD BASED: MARKET ESTIMATES & FORECAST BY REGION,2018-2027 49
7 GLOBAL MICROCRYSTALLINE CELLULOSE MARKET, BY END-USE INDUSTRY
- 7.1 OVERVIEW 51
- 7.1.1 MICROCRYSTALLINE CELLULOSE: MARKET ESTIMATES & FORECAST BY END-USE INDUSTRY, 2018-2027 52
- 7.1.2 MICROCRYSTALLINE CELLULOSE: MARKET ESTIMATES & FORECAST BY END-USE INDUSTRY, 2017-2025 53
- 7.2 PHARMACEUTICALS 54
- 7.2.1 PHARMACEUTICALS: MARKET ESTIMATES & FORECAST BY REGION, 2018-2027 54
- 7.2.2 PHARMACEUTICALS: MARKET ESTIMATES & FORECAST BY REGION, 2018-2027 54
- 7.3 FOOD & BEVERAGE 55
- 7.3.1 FOOD & BEVERAGE: MARKET ESTIMATES & FORECAST BY REGION, 2018-2027 55
- 7.3.2 FOOD & BEVERAGE: MARKET ESTIMATES & FORECAST BY REGION, 2018-2027 56
- 7.4 COSMETIC & PERSONAL CARE 56
- 7.4.1 COSMETIC & PERSONAL CARE: MARKET ESTIMATES & FORECAST BY REGION, 2018-2027 56
- 7.4.2 COSMETIC & PERSONAL CARE: MARKET ESTIMATES & FORECAST BY REGION, 2018-2027 57
- 7.5 OTHERS 57
- 7.5.1 OTHERS: MARKET ESTIMATES & FORECAST BY REGION, 2018-2027 57
- 7.5.2 OTHERS: MARKET ESTIMATES & FORECAST BY REGION, 2018-2027 58
8 GLOBAL MICROCRYSTALLINE CELLULOSE MARKET, BY REGION
- 8.1 OVERVIEW 59
- 8.2 NORTH AMERICA 63
- 8.2.1 US 66
- 8.2.2 CANADA 67
- 8.3 EUROPE 70
- 8.3.1 GERMANY 73
- 8.3.2 UK 75
- 8.3.3 RUSSIA 76
- 8.3.4 FRANCE 78
- 8.3.5 SPAIN 80
- 8.3.6 ITALY 81
- 8.3.7 REST OF EUROPE 83
- 8.4 ASIA-PACIFIC 85
- 8.4.1 CHINA 88
- 8.4.2 JAPAN 90
- 8.4.3 INDIA 91
- 8.4.4 SOUTH KOREA 93
- 8.4.5 AUSTRALIA & NEW ZEALAND 95
- 8.4.6 INDONESIA 97
- 8.4.7 THAILAND 98
- 8.4.8 REST OF ASIA-PACIFIC 100
- 8.5 MIDDLE EAST & AFRICA 102
- 8.5.1 GCC 105
- 8.5.2 ISRAEL 106
- 8.5.3 SOUTH AFRICA 108
- 8.5.4 REST OF MIDDLE EAST & AFRICA 110
- 8.6 LATIN AMERICA 112
- 8.6.1 BRAZIL 115
- 8.6.2 MEXICO 116
- 8.6.3 ARGENTINA 118
- 8.6.4 REST OF LATIN AMERICA 120
9 COMPETITIVE LANDSCAPE
- 9.1 COMPETITIVE OVERVIEW 122
- 9.2 GLOBAL MARKET STRATEGY ANALYSIS 122
- 9.3 COMPETITIVE BENCHMARKING 123
10 COMPANY PROFILES
- 10.1 DUPONT 124
- 10.1.1 COMPANY OVERVIEW 124
- 10.1.2 FINANCIAL OVERVIEW 125
- 10.1.3 PRODUCTS OFFERED 126
- 10.1.4 KEY DEVELOPMENTS 126
- 10.1.5 SWOT ANALYSIS 127
- 10.1.6 KEY STRATEGIES 127
- 10.2 ASAHI KASEI CORPORATION 128
- 10.2.1 COMPANY OVERVIEW 128
- 10.2.2 FINANCIAL OVERVIEW 129
- 10.2.3 PRODUCTS OFFERED 130
- 10.2.4 KEY DEVELOPMENTS 130
- 10.2.5 SWOT ANALYSIS 131
- 10.2.6 KEY STRATEGIES 131
- 10.3 ROQUETTE FRERES 132
- 10.3.1 COMPANY OVERVIEW 132
- 10.3.2 FINANCIAL OVERVIEW 132
- 10.3.3 PRODUCTS OFFERED 132
- 10.3.4 KEY DEVELOPMENTS 132
- 10.3.5 SWOT ANALYSIS 133
- 10.3.6 KEY STRATEGIES 133
- 10.4 MINGTAI CHEMICAL CO., LTD 134
- 10.4.1 COMPANY OVERVIEW 134
- 10.4.2 FINANCIAL OVERVIEW 134
- 10.4.3 PRODUCTS OFFERED 134
- 10.4.4 KEY DEVELOPMENTS 134
- 10.4.5 SWOT ANALYSIS 135
- 10.4.6 KEY STRATEGIES 135
- 10.5 ACCENT MICROCELL PVT. LTD 136
- 10.5.1 COMPANY OVERVIEW 136
- 10.5.2 FINANCIAL OVERVIEW 136
- 10.5.3 PRODUCTS OFFERED 136
- 10.5.4 KEY DEVELOPMENTS 136
- 10.5.5 SWOT ANALYSIS 137
- 10.5.6 KEY STRATEGIES 137
- 10.6 JRS PHARMA 138
- 10.6.1 COMPANY OVERVIEW 138
- 10.6.2 FINANCIAL OVERVIEW 138
- 10.6.3 PRODUCTS OFFERED 138
- 10.6.4 KEY DEVELOPMENTS 139
- 10.6.5 SWOT ANALYSIS 140
- 10.6.6 KEY STRATEGIES 140
- 10.7 PHARMATRANS-SANAQ AG 141
- 10.7.1 COMPANY OVERVIEW 141
- 10.7.2 FINANCIAL OVERVIEW 141
- 10.7.3 PRODUCTS OFFERED 141
- 10.7.4 KEY DEVELOPMENTS 141
- 10.7.5 SWOT ANALYSIS 142
- 10.7.6 KEY STRATEGIES 142
- 10.8 DFE PHARMA 143
- 10.8.1 COMPANY OVERVIEW 143
- 10.8.2 FINANCIAL OVERVIEW 143
- 10.8.3 PRODUCTS OFFERED 143
- 10.8.4 KEY DEVELOPMENTS 143
- 10.8.5 SWOT ANALYSIS 144
- 10.8.6 KEY STRATEGIES 144
- 10.9 WEI MING PHARMACEUTICAL MFG. CO., LTD 145
- 10.9.1 COMPANY OVERVIEW 145
- 10.9.2 FINANCIAL OVERVIEW 145
- 10.9.3 PRODUCTS OFFERED 145
- 10.9.4 KEY DEVELOPMENTS 145
- 10.9.5 SWOT ANALYSIS 146
- 10.9.6 KEY STRATEGIES 146
- 10.10 SIGACHI INDUSTRIES PVT.LTD. 147
- 10.10.1 COMPANY OVERVIEW 147
- 10.10.2 FINANCIAL OVERVIEW 147
- 10.10.3 PRODUCTS OFFERED 147
- 10.10.4 KEY DEVELOPMENTS 147
- 10.10.5 SWOT ANALYSIS 148
- 10.10.6 KEY STRATEGIES 148
11 APPENDIX
- 11.1 REFERENCES 149
- 11.2 RELATED REPORTS 149
